-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $272

Benzinga·11/04/2026 12:39:02
Diffusion vocale
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and lowers the price target from $284 to $272.